AngioDynamics (ANGO)

The company’s portfolio spans both established medical device categories and higher-growth medtech platforms. In vascular care, AngioDynamics offers products used to access, maintain, and treat blood vessels, including catheters, ports, and related devices. Its peripheral vascular products support minimally invasive procedures intended to restore or improve blood flow, while its oncology and surgery offerings include technologies used in ablation and other interventional treatments.

AngioDynamics sells primarily to hospitals, ambulatory surgery centers, and other healthcare providers, with the United States accounting for the majority of revenue. The company competes in markets where clinical performance, physician adoption, reimbursement, and hospital purchasing decisions are key commercial drivers. Its strategy centers on serving procedural specialists with devices that can improve workflow, enable less invasive treatment, or address areas of unmet clinical need.

As a listed medical device company, AngioDynamics is exposed to regulatory requirements, product innovation cycles, and healthcare spending trends. Its performance depends on procedure volumes, the success of newer technologies, and its ability to maintain relevance across competitive vascular and interventional oncology markets.